To begin to assess the clinical relevance of the newly identified PRL-modulated transcripts, we selected the gene product most strongly upregulated by PRL in the in vivo xenotransplant tumors, PTHrP, for protein expression analysis in clinical breast cancer specimens. The gene discussed is PTHLH; the disease is breast carcinoma.